tiprankstipranks
Trending News
More News >
LivaNova PLC (LIVN)
NASDAQ:LIVN
US Market

LivaNova (LIVN) Stock Forecast & Price Target

Compare
271 Followers
See the Price Targets and Ratings of:

LIVN Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
LivaNova
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LIVN Stock 12 Month Forecast

Average Price Target

$64.14
▲(42.00%Upside)
Based on 7 Wall Street analysts offering 12 month price targets for LivaNova in the last 3 months. The average price target is $64.14 with a high forecast of $79.00 and a low forecast of $55.00. The average price target represents a 42.00% change from the last price of $45.17.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"$35","80":"$80","46.25":"$46.3","57.5":"$57.5","68.75":"$68.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$79.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$64.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$55.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,46.25,57.5,68.75,80],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.41,46.1476923076923,48.88538461538461,51.62307692307692,54.36076923076923,57.098461538461535,59.83615384615385,62.573846153846155,65.31153846153846,68.04923076923077,70.78692307692307,73.52461538461539,76.2623076923077,{"y":79,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.41,45.004615384615384,46.599230769230765,48.19384615384615,49.78846153846153,51.38307692307692,52.97769230769231,54.57230769230769,56.16692307692308,57.761538461538464,59.356153846153845,60.95076923076923,62.54538461538462,{"y":64.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.41,44.301538461538456,45.19307692307692,46.08461538461538,46.97615384615384,47.86769230769231,48.75923076923077,49.65076923076923,50.54230769230769,51.433846153846154,52.325384615384614,53.21692307692308,54.10846153846154,{"y":55,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":62.62,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.07,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.48,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.32,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.39,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.6,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.13,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.31,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.95,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.63,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.03,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.79,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.41,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$79.00Average Price Target$64.14Lowest Price Target$55.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on LIVN
TipRanks AITipRanks
Not Ranked
TipRanks
$50
Hold
10.69%
Upside
Reiterated
06/12/25
LivaNova's stock score reflects strong revenue growth and technical momentum as key positives. However, profitability challenges and valuation concerns weigh on the score. Positive earnings call sentiment and clinical trial successes provide a promising outlook, though legal liabilities present risks.
Jefferies
$79
Buy
74.89%
Upside
Reiterated
06/06/25
LivaNova's Strong Growth Potential Driven by Product Innovation and Market Expansion
Barclays Analyst forecast on LIVN
Matt MiksicBarclays
Barclays
$55
Hold
21.76%
Upside
Reiterated
06/05/25
Barclays Remains a Hold on LivaNova (LIVN)
Piper Sandler Analyst forecast on LIVN
Adam MaederPiper Sandler
Piper Sandler
$75
Buy
66.04%
Upside
Reiterated
05/22/25
LivaNova (LIVN) Receives a Buy from Piper Sandler
Wolfe Research Analyst forecast on LIVN
Michael PolarkWolfe Research
Wolfe Research
$60
Buy
32.83%
Upside
Upgraded
05/19/25
Bullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline
Needham
$64
Buy
41.69%
Upside
Reiterated
05/13/25
LivaNova's Resilience: Buy Rating Affirmed Amid Temporary Setbacks and Future Growth Prospects
Mizuho Securities Analyst forecast on LIVN
Anthony PetroneMizuho Securities
Mizuho Securities
$50$55
Buy
21.76%
Upside
Reiterated
05/08/25
Livanova (LIVN) PT Raised to $55 at MizuhoMizuho analyst Anthony Petrone raised the price target on Livanova (NASDAQ: LIVN) to $55.00 (from $50.00) while maintaining a Outperform rating.
Robert W. Baird Analyst forecast on LIVN
David RescottRobert W. Baird
Robert W. Baird
$55$61
Buy
35.05%
Upside
Reiterated
05/08/25
LivaNova price target raised to $61 from $55 at BairdLivaNova price target raised to $61 from $55 at Baird
Goldman Sachs Analyst forecast on LIVN
David RomanGoldman Sachs
Goldman Sachs
$55
Buy
21.76%
Upside
Reiterated
03/09/25
Positive Outlook for LivaNova Driven by Product Upgrades and Market ExpansionWe hosted Vlad Makatsaria (CEO), Alex Shvartsburg (CFO), and Briana Gotlin (VP , Investor Relations) for investor meetings in Chicago, where key focus areas included: (1) core business growth trajectory; (2) pipeline development; (3) operating margin expansion opportunities; and (4) capital allocation priorities. These investor meetings followed the company’s 4Q24 results and introduction of 2025 guidance with LIVN shares underperforming YTD (-16% vs. the Russel 2000 -7%). Investor debate around the stock has intensified surrounding underlying durability of the base business, path to realizing positive returns from pipeline investments in new growth categories, and the corresponding impact on the P&L, in our view. Fundamental dynamics also continue to face the overhang of outstanding litigation (SNIA), where the company expects to have a more detailed update later in 1H25.
Stifel Nicolaus Analyst forecast on LIVN
Rick WiseStifel Nicolaus
Stifel Nicolaus
$72$60
Buy
32.83%
Upside
Reiterated
02/25/25
Livanova (LIVN) PT Lowered to $60 at StifelStifel analyst Rick Wise lowered the price target on Livanova (NASDAQ: LIVN) to $60.00 (from $72.00) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on LIVN
TipRanks AITipRanks
Not Ranked
TipRanks
$50
Hold
10.69%
Upside
Reiterated
06/12/25
LivaNova's stock score reflects strong revenue growth and technical momentum as key positives. However, profitability challenges and valuation concerns weigh on the score. Positive earnings call sentiment and clinical trial successes provide a promising outlook, though legal liabilities present risks.
Jefferies
$79
Buy
74.89%
Upside
Reiterated
06/06/25
LivaNova's Strong Growth Potential Driven by Product Innovation and Market Expansion
Barclays Analyst forecast on LIVN
Matt MiksicBarclays
Barclays
$55
Hold
21.76%
Upside
Reiterated
06/05/25
Barclays Remains a Hold on LivaNova (LIVN)
Piper Sandler Analyst forecast on LIVN
Adam MaederPiper Sandler
Piper Sandler
$75
Buy
66.04%
Upside
Reiterated
05/22/25
LivaNova (LIVN) Receives a Buy from Piper Sandler
Wolfe Research Analyst forecast on LIVN
Michael PolarkWolfe Research
Wolfe Research
$60
Buy
32.83%
Upside
Upgraded
05/19/25
Bullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline
Needham
$64
Buy
41.69%
Upside
Reiterated
05/13/25
LivaNova's Resilience: Buy Rating Affirmed Amid Temporary Setbacks and Future Growth Prospects
Mizuho Securities Analyst forecast on LIVN
Anthony PetroneMizuho Securities
Mizuho Securities
$50$55
Buy
21.76%
Upside
Reiterated
05/08/25
Livanova (LIVN) PT Raised to $55 at MizuhoMizuho analyst Anthony Petrone raised the price target on Livanova (NASDAQ: LIVN) to $55.00 (from $50.00) while maintaining a Outperform rating.
Robert W. Baird Analyst forecast on LIVN
David RescottRobert W. Baird
Robert W. Baird
$55$61
Buy
35.05%
Upside
Reiterated
05/08/25
LivaNova price target raised to $61 from $55 at BairdLivaNova price target raised to $61 from $55 at Baird
Goldman Sachs Analyst forecast on LIVN
David RomanGoldman Sachs
Goldman Sachs
$55
Buy
21.76%
Upside
Reiterated
03/09/25
Positive Outlook for LivaNova Driven by Product Upgrades and Market ExpansionWe hosted Vlad Makatsaria (CEO), Alex Shvartsburg (CFO), and Briana Gotlin (VP , Investor Relations) for investor meetings in Chicago, where key focus areas included: (1) core business growth trajectory; (2) pipeline development; (3) operating margin expansion opportunities; and (4) capital allocation priorities. These investor meetings followed the company’s 4Q24 results and introduction of 2025 guidance with LIVN shares underperforming YTD (-16% vs. the Russel 2000 -7%). Investor debate around the stock has intensified surrounding underlying durability of the base business, path to realizing positive returns from pipeline investments in new growth categories, and the corresponding impact on the P&L, in our view. Fundamental dynamics also continue to face the overhang of outstanding litigation (SNIA), where the company expects to have a more detailed update later in 1H25.
Stifel Nicolaus Analyst forecast on LIVN
Rick WiseStifel Nicolaus
Stifel Nicolaus
$72$60
Buy
32.83%
Upside
Reiterated
02/25/25
Livanova (LIVN) PT Lowered to $60 at StifelStifel analyst Rick Wise lowered the price target on Livanova (NASDAQ: LIVN) to $60.00 (from $72.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering LivaNova

1 Month
xxx
Success Rate
14/21 ratings generated profit
67%
Average Return
+2.93%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.93% per trade.
3 Months
xxx
Success Rate
11/23 ratings generated profit
48%
Average Return
-3.63%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 47.83% of your transactions generating a profit, with an average return of -3.63% per trade.
1 Year
Adam MaederPiper Sandler
Success Rate
8/21 ratings generated profit
38%
Average Return
-9.94%
reiterated a buy rating 30 days ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 38.10% of your transactions generating a profit, with an average return of -9.94% per trade.
2 Years
xxx
Success Rate
10/28 ratings generated profit
36%
Average Return
-12.72%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of -12.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LIVN Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
2
4
4
5
4
Buy
8
6
5
7
6
Hold
4
5
4
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
15
13
15
12
In the current month, LIVN has received 10 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LIVN average Analyst price target in the past 3 months is 64.14.
Each month's total comprises the sum of three months' worth of ratings.

LIVN Financial Forecast

LIVN Earnings Forecast

Next quarter’s earnings estimate for LIVN is $0.87 with a range of $0.82 to $0.97. The previous quarter’s EPS was $0.88. LIVN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year LIVN has Outperformed its overall industry.
Next quarter’s earnings estimate for LIVN is $0.87 with a range of $0.82 to $0.97. The previous quarter’s EPS was $0.88. LIVN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year LIVN has Outperformed its overall industry.

LIVN Sales Forecast

Next quarter’s sales forecast for LIVN is $332.26M with a range of $329.00M to $337.85M. The previous quarter’s sales results were $316.86M. LIVN beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year LIVN has Outperformed its overall industry.
Next quarter’s sales forecast for LIVN is $332.26M with a range of $329.00M to $337.85M. The previous quarter’s sales results were $316.86M. LIVN beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year LIVN has Outperformed its overall industry.

LIVN Stock Forecast FAQ

What is LIVN’s average 12-month price target, according to analysts?
Based on analyst ratings, LivaNova PLC’s 12-month average price target is 64.14.
    What is LIVN’s upside potential, based on the analysts’ average price target?
    LivaNova PLC has 42.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is LIVN a Buy, Sell or Hold?
          LivaNova PLC has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is LivaNova PLC’s price target?
            The average price target for LivaNova PLC is 64.14. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $79.00 ,the lowest forecast is $55.00. The average price target represents 42.00% Increase from the current price of $45.17.
              What do analysts say about LivaNova PLC?
              LivaNova PLC’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of LIVN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis